Last updated on September 2018

Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma


Brief description of study

A Phase III, randomised study of atezolizumab alone and in combination with chemotherapy versus chemotherapy alone in participants with untreated advanced urothelial cancer.

Clinical Study Identifier: NCT02807636

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: WO30070 ...

Chongqing Cancer Hospital
Chongqing, China